Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 18 October 1996:
Vol. 274. no. 5286, pp. 342 - 0
DOI: 10.1126/science.274.5286.342
Prev | Table of Contents | Next

Research News

Elizabeth Pennisi

Research reported in this issue (p. 373) indicates that a modified version of a virus best known as a cause of respiratory infections may provide an intriguing new way to kill cancer cells while leaving normal cells unharmed.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Coadministration of a Herpes Simplex Virus-2 Based Oncolytic Virus and Cyclophosphamide Produces a Synergistic Antitumor Effect and Enhances Tumor-Specific Immune Responses.
H. Li, Z. Zeng, X. Fu, and X. Zhang (2007)
Cancer Res. 67, 7850-7855
   Abstract »    Full Text »    PDF »
Effective treatment of pancreatic cancer xenografts with a conditionally replicating virus derived from type 2 herpes simplex virus..
X. Fu, L. Tao, M. Li, W. E. Fisher, and X. Zhang (2006)
Clin. Cancer Res. 12, 3152-3157
   Abstract »    Full Text »    PDF »
Potent Systemic Antitumor Activity from an Oncolytic Herpes Simplex Virus of Syncytial Phenotype.
X. Fu and X. Zhang (2002)
Cancer Res. 62, 2306-2312
   Abstract »    Full Text »    PDF »
Biochemical and Genetic Control of Apoptosis: Relevance to Normal Hematopoiesis and Hematological Malignancies.
R. G. Wickremasinghe and A. V. Hoffbrand (1999)
Blood 93, 3587-3600
   Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)